CDKN2B anticorps

N° du produit ABIN7182212

Détail du produit anti-CDKN2B anticorps

Antigène: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CDKN2B est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain, Souris, Rat

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: Synthesized peptide derived from Human p15 INK antibody.

Isotype: IgG

Information d'application

Indications d'application: WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CDKN2B

Antigène: CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))

Autre désignation: CDKN2B (CDKN2B Produits)

Synonymes: anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b

Sujet:

Background: Interacts strongly with CDK4 and CDK6. Potent inhibitor. Potential effector of TGF-beta induced cell cycle arrest.

Nynke Y. Rots, Blood, Apr 1999, 93: 2721 - 2729.
Stefan Faderl, Clin. Cancer Res., Jul 1999, 5: 1855.
George Wu, Mol. Biol. Cell, Mar 2007, 18: 1018 - 1029.
A. Koenig, Vet. Pathol., Jul 2002, 39: 458.

Aliases: CDK inhibitory protein antibody, CDK4B Inhibitor antibody, Cdkn2b antibody, CDN2B_HUMAN antibody, Cyclin dependent kinase 4 inhibitor B antibody, Cyclin Dependent Kinase Inhibitor 2B antibody, Cyclin dependent kinase inhibitor 2B p15 inhibits CDK4 antibody, Cyclin dependent kinases 4 and 6 binding protein antibody, Cyclin-dependent kinase 4 inhibitor B antibody, INK4B antibody, MTS 2 antibody, MTS-2 antibody, MTS2 antibody, Multiple tumor suppressor 2 antibody, Multiple Tumor Supressor 2 antibody, OTTHUMP00000021154 antibody, OTTHUMP00000021155 antibody, p14 CDK inhibitor antibody, p14 INK4b antibody, p14-INK4b antibody, P15 antibody, p15 CDK inhibitor antibody, p15 inhibits CDK4 antibody, p15 INK4b antibody, p15-INK4b antibody, p15INK4B antibody, TP 15 antibody, TP15 antibody

UniProt: P42772

Pathways: Cycle Cellulaire, Mitotic G1-G1/S Phases